Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy Combined With PD-1 Inhibitors and GM-CSF in Advanced Recurrent Metastatic Head and Neck Tumors
NCT05760196Phase 2Unknown
- Start
- Oct 2022
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in head and neck cancer (HNC). Status: unknown.
02
Drugs
sargramostim
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT05760196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05760196.